Doxorubicin cardiotoxicity detected by indium 111 myosin-specific imaging
Identifieur interne : 000386 ( Main/Exploration ); précédent : 000385; suivant : 000387Doxorubicin cardiotoxicity detected by indium 111 myosin-specific imaging
Auteurs : RBID : ISTEX:259_1991_Article_BF02262734.pdfEnglish descriptors
Abstract
A patient with primary hepatoma, treated with doxorubicin and presenting with atypical electrocardiographic findings, was investigated with myosin-specific monoclonal antibody radiolabelled with indium-111. Despite a normal ejection fraction, myosin-specific scintigraphy was positive, indicating doxorubicin cardiotoxicity.
DOI: 10.1007/BF02262734
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title>Doxorubicin cardiotoxicity detected by indium 111 myosin-specific imaging</title><author><name>John Lekakis</name><affiliation wicri:level="1"><mods:affiliation>Department of Clinical Therapeutics, Athens University, Greece</mods:affiliation><country xml:lang="fr">Grèce</country><wicri:regionArea>Department of Clinical Therapeutics, Athens University</wicri:regionArea><wicri:noRegion>Athens University</wicri:noRegion></affiliation><affiliation wicri:level="1"><mods:affiliation>Department of Nuclear Medicine, Alexandra Hospital, Athens, Greece</mods:affiliation><country xml:lang="fr">Grèce</country><wicri:regionArea>Department of Nuclear Medicine, Alexandra Hospital, Athens</wicri:regionArea><wicri:noRegion>Athens</wicri:noRegion></affiliation></author><author><name>Nikos Vassilopoulos</name><affiliation wicri:level="1"><mods:affiliation>Department of Clinical Therapeutics, Athens University, Greece</mods:affiliation><country xml:lang="fr">Grèce</country><wicri:regionArea>Department of Clinical Therapeutics, Athens University</wicri:regionArea><wicri:noRegion>Athens University</wicri:noRegion></affiliation><affiliation wicri:level="1"><mods:affiliation>Department of Nuclear Medicine, Alexandra Hospital, Athens, Greece</mods:affiliation><country xml:lang="fr">Grèce</country><wicri:regionArea>Department of Nuclear Medicine, Alexandra Hospital, Athens</wicri:regionArea><wicri:noRegion>Athens</wicri:noRegion></affiliation></author><author><name>Helen Psichoyiou</name><affiliation wicri:level="1"><mods:affiliation>Department of Clinical Therapeutics, Athens University, Greece</mods:affiliation><country xml:lang="fr">Grèce</country><wicri:regionArea>Department of Clinical Therapeutics, Athens University</wicri:regionArea><wicri:noRegion>Athens University</wicri:noRegion></affiliation><affiliation wicri:level="1"><mods:affiliation>Department of Nuclear Medicine, Alexandra Hospital, Athens, Greece</mods:affiliation><country xml:lang="fr">Grèce</country><wicri:regionArea>Department of Nuclear Medicine, Alexandra Hospital, Athens</wicri:regionArea><wicri:noRegion>Athens</wicri:noRegion></affiliation></author><author><name>Peter Athanassiadis</name><affiliation wicri:level="1"><mods:affiliation>Department of Clinical Therapeutics, Athens University, Greece</mods:affiliation><country xml:lang="fr">Grèce</country><wicri:regionArea>Department of Clinical Therapeutics, Athens University</wicri:regionArea><wicri:noRegion>Athens University</wicri:noRegion></affiliation><affiliation wicri:level="1"><mods:affiliation>Department of Nuclear Medicine, Alexandra Hospital, Athens, Greece</mods:affiliation><country xml:lang="fr">Grèce</country><wicri:regionArea>Department of Nuclear Medicine, Alexandra Hospital, Athens</wicri:regionArea><wicri:noRegion>Athens</wicri:noRegion></affiliation></author><author><name>Sofia Gerali</name><affiliation wicri:level="1"><mods:affiliation>Department of Clinical Therapeutics, Athens University, Greece</mods:affiliation><country xml:lang="fr">Grèce</country><wicri:regionArea>Department of Clinical Therapeutics, Athens University</wicri:regionArea><wicri:noRegion>Athens University</wicri:noRegion></affiliation><affiliation wicri:level="1"><mods:affiliation>Department of Nuclear Medicine, Alexandra Hospital, Athens, Greece</mods:affiliation><country xml:lang="fr">Grèce</country><wicri:regionArea>Department of Nuclear Medicine, Alexandra Hospital, Athens</wicri:regionArea><wicri:noRegion>Athens</wicri:noRegion></affiliation></author><author><name>Panos Kostamis</name><affiliation wicri:level="1"><mods:affiliation>Department of Clinical Therapeutics, Athens University, Greece</mods:affiliation><country xml:lang="fr">Grèce</country><wicri:regionArea>Department of Clinical Therapeutics, Athens University</wicri:regionArea><wicri:noRegion>Athens University</wicri:noRegion></affiliation><affiliation wicri:level="1"><mods:affiliation>Department of Nuclear Medicine, Alexandra Hospital, Athens, Greece</mods:affiliation><country xml:lang="fr">Grèce</country><wicri:regionArea>Department of Nuclear Medicine, Alexandra Hospital, Athens</wicri:regionArea><wicri:noRegion>Athens</wicri:noRegion></affiliation></author><author><name>Spyridon Moulopoulos</name><affiliation wicri:level="1"><mods:affiliation>Department of Clinical Therapeutics, Athens University, Greece</mods:affiliation><country xml:lang="fr">Grèce</country><wicri:regionArea>Department of Clinical Therapeutics, Athens University</wicri:regionArea><wicri:noRegion>Athens University</wicri:noRegion></affiliation><affiliation wicri:level="1"><mods:affiliation>Department of Nuclear Medicine, Alexandra Hospital, Athens, Greece</mods:affiliation><country xml:lang="fr">Grèce</country><wicri:regionArea>Department of Nuclear Medicine, Alexandra Hospital, Athens</wicri:regionArea><wicri:noRegion>Athens</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="RBID">ISTEX:259_1991_Article_BF02262734.pdf</idno><date when="1991">1991</date><idno type="doi">10.1007/BF02262734</idno><idno type="wicri:Area/Main/Corpus">000706</idno><idno type="wicri:Area/Main/Curation">000706</idno><idno type="wicri:Area/Main/Exploration">000386</idno></publicationStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Doxorubicin cardiotoxicity</term><term>Indium 111 antimyosin</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="eng">A patient with primary hepatoma, treated with doxorubicin and presenting with atypical electrocardiographic findings, was investigated with myosin-specific monoclonal antibody radiolabelled with indium-111. Despite a normal ejection fraction, myosin-specific scintigraphy was positive, indicating doxorubicin cardiotoxicity.</div></front></TEI><mods xsi:schemaLocation="http://www.loc.gov/mods/v3 file:///applis/istex/home/loadistex/home/etc/xsd/mods.xsd" version="3.4" istexId="78083916ca1a3266979f5016ae9dfb8a7732658f"><titleInfo lang="eng"><title>Doxorubicin cardiotoxicity detected by indium 111 myosin-specific imaging</title></titleInfo><name type="personal"><namePart type="given">John</namePart><namePart type="family">Lekakis</namePart><role><roleTerm type="text">author</roleTerm></role><affiliation>Department of Clinical Therapeutics, Athens University, Greece</affiliation><affiliation>Department of Nuclear Medicine, Alexandra Hospital, Athens, Greece</affiliation></name><name type="personal"><namePart type="given">Nikos</namePart><namePart type="family">Vassilopoulos</namePart><role><roleTerm type="text">author</roleTerm></role><affiliation>Department of Clinical Therapeutics, Athens University, Greece</affiliation><affiliation>Department of Nuclear Medicine, Alexandra Hospital, Athens, Greece</affiliation></name><name type="personal"><namePart type="given">Helen</namePart><namePart type="family">Psichoyiou</namePart><role><roleTerm type="text">author</roleTerm></role><affiliation>Department of Clinical Therapeutics, Athens University, Greece</affiliation><affiliation>Department of Nuclear Medicine, Alexandra Hospital, Athens, Greece</affiliation></name><name type="personal"><namePart type="given">Peter</namePart><namePart type="family">Athanassiadis</namePart><role><roleTerm type="text">author</roleTerm></role><affiliation>Department of Clinical Therapeutics, Athens University, Greece</affiliation><affiliation>Department of Nuclear Medicine, Alexandra Hospital, Athens, Greece</affiliation></name><name type="personal"><namePart type="given">Sofia</namePart><namePart type="family">Gerali</namePart><role><roleTerm type="text">author</roleTerm></role><affiliation>Department of Clinical Therapeutics, Athens University, Greece</affiliation><affiliation>Department of Nuclear Medicine, Alexandra Hospital, Athens, Greece</affiliation></name><name type="personal"><namePart type="given">Panos</namePart><namePart type="family">Kostamis</namePart><role><roleTerm type="text">author</roleTerm></role><affiliation>Department of Clinical Therapeutics, Athens University, Greece</affiliation><affiliation>Department of Nuclear Medicine, Alexandra Hospital, Athens, Greece</affiliation></name><name type="personal"><namePart type="given">Spyridon</namePart><namePart type="family">Moulopoulos</namePart><role><roleTerm type="text">author</roleTerm></role><affiliation>Department of Clinical Therapeutics, Athens University, Greece</affiliation><affiliation>Department of Nuclear Medicine, Alexandra Hospital, Athens, Greece</affiliation></name><typeOfResource>text</typeOfResource><genre>Case Report</genre><genre>Original Paper</genre><originInfo><publisher>Springer-Verlag, Berlin/Heidelberg</publisher><dateCreated encoding="w3cdtf">1990-07-02</dateCreated><dateValid encoding="w3cdtf">2005-11-10</dateValid><copyrightDate encoding="w3cdtf">1991</copyrightDate></originInfo><language><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType></physicalDescription><abstract lang="eng">A patient with primary hepatoma, treated with doxorubicin and presenting with atypical electrocardiographic findings, was investigated with myosin-specific monoclonal antibody radiolabelled with indium-111. Despite a normal ejection fraction, myosin-specific scintigraphy was positive, indicating doxorubicin cardiotoxicity.</abstract><subject lang="eng"><genre>Key words</genre><topic>Doxorubicin cardiotoxicity</topic><topic>Indium 111 antimyosin</topic></subject><relatedItem type="series"><titleInfo type="abbreviated"><title>Eur J Nucl Med</title></titleInfo><titleInfo><title>European Journal of Nuclear Medicine</title><partNumber>Year: 1991</partNumber><partNumber>Volume: 18</partNumber><partNumber>Number: 3</partNumber></titleInfo><genre>Archive Journal</genre><originInfo><dateIssued encoding="w3cdtf">1991-03-01</dateIssued><copyrightDate encoding="w3cdtf">1991</copyrightDate></originInfo><subject usage="primary"><topic>Medicine & Public Health</topic><topic>Imaging / Radiology</topic><topic>Nuclear Medicine</topic></subject><identifier type="issn">0340-6997</identifier><identifier type="issn">Electronic: 1619-7089</identifier><identifier type="matrixNumber">259</identifier><identifier type="local">IssueArticleCount: 12</identifier><recordInfo><recordOrigin>Springer-Verlag, 1991</recordOrigin></recordInfo></relatedItem><identifier type="doi">10.1007/BF02262734</identifier><identifier type="matrixNumber">Art12</identifier><identifier type="local">BF02262734</identifier><accessCondition type="use and reproduction">MetadataGrant: OpenAccess</accessCondition><accessCondition type="use and reproduction">AbstractGrant: OpenAccess</accessCondition><accessCondition type="restriction on access">BodyPDFGrant: Restricted</accessCondition><accessCondition type="restriction on access">BodyHTMLGrant: Restricted</accessCondition><accessCondition type="restriction on access">BibliographyGrant: Restricted</accessCondition><accessCondition type="restriction on access">ESMGrant: Restricted</accessCondition><part><extent unit="pages"><start>225</start><end>226</end></extent></part><recordInfo><recordOrigin>Springer-Verlag, 1991</recordOrigin><recordIdentifier>259_1991_Article_BF02262734.pdf</recordIdentifier></recordInfo></mods></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=IndiumV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000386 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000386 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= *** parameter Area/wikiCode missing ***
|area= IndiumV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:259_1991_Article_BF02262734.pdf
|texte= Doxorubicin cardiotoxicity detected by indium 111 myosin-specific imaging
}}
| This area was generated with Dilib version V0.5.81. |  |